Similar to the experiments with TNF stimulation in H-FLS, glycolysis inhibition with 2-DG tended to reduce secretion of MCP-3 and MMP1 in FLS from RA patients (Fig. 5c). This evidence concerns the gene MMP1 and rheumatoid arthritis.